Vertex Pharmaceuticals won FDA approval for its non-opioid painkiller Journavx. Vertex stock jumped in late trading.

The FDA’s official account on X also tweeted the news — the agency’s first post since President Donald Trump was inaugurated. Though the agency approved the drug to treat acute, short-term pain, ...

ByteDance’s OmniHuman-1 generates lifelike human videos from a single image and audio. Discover its key features and compare it with Sora and Veo 2.

Also, U.S. average hourly earnings rose +0.5% m/m and +4.1% y/y in January, stronger than expectations of ... weaker than expectations of 49.7. U.S. Steel (X) rose over +8% in pre-market trading after ...

Analyst Salveen Richter of Goldman Sachs maintained a Buy rating on Vertex Pharmaceuticals (VRTX – Research Report), reducing the price target ...

Vertex just won approval for a drug to treat one of the most common health problems -- pain. The biotech company is offering an option for patients and doctors who don’t want to go for ...

The FDA recently approved Journavx for treating acute pain. This approval is tremendously important for Vertex Pharmaceuticals. The biotech company has also received other good news over the last ...

Companies in the Healthcare sector have received a lot of coverage today as analysts weigh in on Oric Pharmaceuticals (ORIC – Research ...

JOSEPH PREZIOSO / AFP via Getty Images Vertex Pharmaceuticals' non-opioid painkiller received approval from the Food and Drug Administration. The drugmaker said the twice-daily pill, Journavx ...

HOUSTON, January 22, 2025--(BUSINESS WIRE)--Vertex Energy, Inc. ("Vertex" or the "Company"), a leading specialty refiner and marketer of high-quality refined products, together with its affiliates ...

Google released Gemini 2.0 Flash for Google AI Studio and Vertex AI. The “Flash” in this model’s name means that it’s a model focused on speed. You’ll want to use this model if you want ...